Hall H, Ross S B, Sällemark M
J Neural Transm. 1984;59(1):9-23. doi: 10.1007/BF01249875.
The dependence of intact noradrenergic and serotonergic nerve terminals for the decrease in the number of beta-adrenoceptors and 5-HT2 binding sites in the cerebral cortex produced by long-term treatment of rats with antidepressant drugs was examined. Noradrenergic nerve terminals were destroyed with the selective noradrenaline neurotoxin DSP4, and serotonergic nerve terminals were destroyed with p-chloroamphetamine (PCA). It was found that lesioning of the noradrenergic nerve terminals abolished the decrease in beta-adrenoceptors produced by desipramine, mianserin and zimeldine and partially antagonized that of the beta-adrenoceptor agonist clenbuterol. PCA pretreatment did not antagonize the long-term effects on the beta-adrenoceptor produced by these compounds. Lesioning of serotonergic nerve terminals affected the down-regulation of 5-HT2 binding sites produced by long-term treatment with mianserin, desipramine and amiflamine. DSP4 pretreatment partially abolished the down-regulation of 5-HT2 binding sites produced by long-term treatment with desipramine, while the effects of mianserin and amiflamine were unaffected by pretreatment with DSP4.
研究了完整的去甲肾上腺素能和5-羟色胺能神经末梢对长期用抗抑郁药治疗的大鼠大脑皮质中β-肾上腺素能受体数量减少和5-HT2结合位点减少的依赖性。用选择性去甲肾上腺素神经毒素DSP4破坏去甲肾上腺素能神经末梢,用对氯苯丙胺(PCA)破坏5-羟色胺能神经末梢。结果发现,去甲肾上腺素能神经末梢受损消除了地昔帕明、米安色林和齐美利定引起的β-肾上腺素能受体减少,并部分拮抗了β-肾上腺素能受体激动剂克伦特罗引起的减少。PCA预处理并未拮抗这些化合物对β-肾上腺素能受体产生的长期影响。5-羟色胺能神经末梢受损影响了长期用米安色林、地昔帕明和阿米氟胺治疗引起的5-HT2结合位点下调。DSP4预处理部分消除了长期用地昔帕明治疗引起的5-HT2结合位点下调,而米安色林和阿米氟胺的作用不受DSP4预处理的影响。